Vasodilator-stimulated phosphoprotein-phosphorylation by ginsenoside Ro inhibits fibrinogen binding to αIIb/β 3 in thrombin-induced human platelets.

We demonstrate that G-Ro is a beneficial novel compound inhibiting αIIb/β-mediated fibrinogen binding, and may prevent platelet aggregation-mediated thrombotic disease.